1. Apolipoprotein E deficiency and high-fat diet cooperate to trigger lipidosis and inflammation in the lung via the toll-like receptor 4 pathway
   QIUFANG OUYANG et al, 2015, Molecular Medicine Reports CrossRef
2. Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models
   Dong Yun Kim et al, 2023, Biomedicine & Pharmacotherapy CrossRef
3. Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered
   William B. Kinlaw et al, 2016, Journal of Cellular Physiology CrossRef
4. Regulation of the expression of cholesterol transporters by lipid-lowering drugs ezetimibe and pemafibrate in rat liver and intestine
   Yuji Tanaka et al, 2021, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
5. CM3-SII polysaccharide obtained from Cordyceps militaris ameliorates hyperlipidemia in heterozygous LDLR-deficient hamsters by modulating gut microbiota and NPC1L1 and PPARα levels
   Wen-Qian Yu et al, 2023, International Journal of Biological Macromolecules CrossRef
6. Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague–Dawley Rats
   Raghdaa Al Zarzour et al, 2017, Nutrients CrossRef
7. Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
   In Cheol Yoon et al, 2019, Yeungnam University Journal of Medicine CrossRef
8. Soybean Oil-Derived Poly-Unsaturated Fatty Acids Enhance Liver Damage in NAFLD Induced by Dietary Cholesterol
   Janin Henkel et al, 2018, Nutrients CrossRef
9. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice
   Rajni Kant et al, 2020, Biomedicine & Pharmacotherapy CrossRef
10. Curcumin protects against high-fat diet-induced nonalcoholic simple fatty liver by inhibiting intestinal and hepatic NPC1L1 expression via down-regulation of SREBP-2/HNF1α pathway in hamsters
    Jie Yang et al, 2023, The Journal of Nutritional Biochemistry CrossRef
11. Chitobiose alleviates oleic acid-induced lipid accumulation by decreasing fatty acid uptake and triglyceride synthesis in HepG2 cells
    Xiaodan Li et al, 2018, Journal of Functional Foods CrossRef
12. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease
    Takashi Nakahara et al, 2018, Journal of Gastroenterology CrossRef
13. Anti-obesity and anti-hepatosteatosis effects of dietary scopoletin in high-fat diet fed mice
    Ju Ri Ham et al, 2016, Journal of Functional Foods CrossRef
14. Podocyte Lipotoxicity in CKD
    Jin-Ju Kim et al, 2021, Kidney360 CrossRef
15. Approaches for modifying cellular cholesterol levels and their application to mechanistic studies: Examples from the ion channel field
    Avia Rosenhouse-Dantsker et al, 2022, Cholesterol CrossRef
16. The Critical Role of microRNA-21 in Non-alcoholic Fatty Liver Disease Pathogenesis
    Mingjing Liu et al, 2023, Current Pharmaceutical Design CrossRef
17. Polysaccharide CM1 from Cordyceps militaris hinders adipocyte differentiation and alleviates hyperlipidemia in LDLR(+/−) hamsters
    Wen-Qian Yu et al, 2021, Lipids in Health and Disease CrossRef
18. Is there a role of lipid-lowering therapies in the management of fatty liver disease?
    Ismini Tzanaki et al, 2022, World Journal of Hepatology CrossRef